83 related articles for article (PubMed ID: 1567158)
1. Treatment of malignant midgut carcinoid with a highly purified human leukocyte alpha-interferon.
Ahren B; Engman K; Lindblom A
Anticancer Res; 1992; 12(1):129-33. PubMed ID: 1567158
[TBL] [Abstract][Full Text] [Related]
2. Tolerance to long-term treatment of malignant midgut carcinoid with a highly purified human leukocyte alpha-interferon.
Ahren B; Engman K; Lindblom A
Anticancer Res; 1992; 12(3):881-4. PubMed ID: 1622146
[TBL] [Abstract][Full Text] [Related]
3. Interferon treatment in patients with malignant carcinoids.
Nobin A; Lindblom A; Månsson B; Sundberg M
Acta Oncol; 1989; 28(3):445-9. PubMed ID: 2742782
[TBL] [Abstract][Full Text] [Related]
4. Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours.
Kölby L; Persson G; Franzén S; Ahrén B
Br J Surg; 2003 Jun; 90(6):687-93. PubMed ID: 12808615
[TBL] [Abstract][Full Text] [Related]
5. Treatment of malignant metastatic midgut carcinoid tumours with recombinant human alpha2b interferon with or without prior hepatic artery embolization.
Hanssen LE; Schrumpf E; Kolbenstvedt AN; Tausjø J; Dolva LO
Scand J Gastroenterol; 1989 Sep; 24(7):787-95. PubMed ID: 2477894
[TBL] [Abstract][Full Text] [Related]
6. Combined alpha- and gamma-interferon therapy for malignant midgut carcinoid tumors. A phase I-II trial.
Janson ET; Kauppinen HL; Oberg K
Acta Oncol; 1993; 32(2):231-3. PubMed ID: 8323762
[TBL] [Abstract][Full Text] [Related]
7. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome.
Oberg K; Funa K; Alm G
N Engl J Med; 1983 Jul; 309(3):129-33. PubMed ID: 6191217
[TBL] [Abstract][Full Text] [Related]
8. Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome).
de Herder WW
Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):705-15. PubMed ID: 16253895
[TBL] [Abstract][Full Text] [Related]
9. Anemia in patients with midgut carcinoid, treated with alpha interferon: effects by erythropoietin treatment on the perceived quality of life.
Larsson G; Janson ET
Eur J Cancer Care (Engl); 2008 Mar; 17(2):200-4. PubMed ID: 18302658
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the natural killer cell-interferon system in patients with mid-gut carcinoid tumours treated with leucocyte interferon.
Funa K; Alm GV; Rönnblom L; Oberg K
Clin Exp Immunol; 1983 Sep; 53(3):716-24. PubMed ID: 6616963
[TBL] [Abstract][Full Text] [Related]
11. Treatment of gastrointestinal endocrine tumours with interferon-alpha and octreotide.
Creutzfeldt W; Bartsch HH; Jacubaschke U; Stöckmann F
Acta Oncol; 1991; 30(4):529-35. PubMed ID: 1713038
[TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study.
Jacobsen MB; Hanssen LE; Kolmannskog F; Schrumpf E; Vatn MH; Bergan A
Scand J Gastroenterol; 1995 Aug; 30(8):789-96. PubMed ID: 7481548
[TBL] [Abstract][Full Text] [Related]
13. [Individual therapeutic procedure in metastatic carcinoid of the small intestine].
Barthel A; Leonhardt U; Stöckmann F; Ramadori G
Leber Magen Darm; 1996 May; 26(3):164, 167-9. PubMed ID: 8709831
[TBL] [Abstract][Full Text] [Related]
14. Recombinant alpha-2 interferon with or without hepatic artery embolization in the treatment of midgut carcinoid tumours. A preliminary report.
Hanssen LE; Schrumpf E; Kolbenstvedt AN; Tausjø J; Dolva LO
Acta Oncol; 1989; 28(3):439-43. PubMed ID: 2742781
[TBL] [Abstract][Full Text] [Related]
15. Description of patients with midgut carcinoid tumours: clinical database from a Danish centre.
Nykjaer KM; Grønbaek H; Nielsen DT; Christiansen P; Astrup LB
In Vivo; 2007; 21(4):679-84. PubMed ID: 17708366
[TBL] [Abstract][Full Text] [Related]
16. Levels of angiogenic peptides in sera from patients with carcinoid tumours during alpha-interferon treatment.
Nilsson A; Janson ET; Eriksson B; Larsson A
Anticancer Res; 2001; 21(6A):4087-90. PubMed ID: 11911297
[TBL] [Abstract][Full Text] [Related]
17. Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors.
Eriksson BK; Larsson EG; Skogseid BM; Löfberg AM; Lörelius LE; Oberg KE
Cancer; 1998 Dec; 83(11):2293-301. PubMed ID: 9840528
[TBL] [Abstract][Full Text] [Related]
18. Extended experience with recombinant alpha-2b interferon with or without hepatic artery embolization in the treatment of midgut carcinoid tumours. A preliminary report.
Hanssen LE; Schrumpf E; Jacobsen MB; Kolbenstvedt AN; Kolmannskog F; Bergan A; Dolva LO
Acta Oncol; 1991; 30(4):523-7. PubMed ID: 1854510
[TBL] [Abstract][Full Text] [Related]
19. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
Smith DB; Scarffe JH; Wagstaff J; Johnston RJ
Cancer Treat Rep; 1987 Dec; 71(12):1265-6. PubMed ID: 3690534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
